CHOLINERGIC ACTIVATION: AUTOMATICITY AND CONDUCTION
胆碱能激活:自动性和传导
基本信息
- 批准号:3340183
- 负责人:
- 金额:$ 8.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-07-01 至 1987-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The cardiovascular effects of acetylcholine include alterations in
automaticity, conduction, coronary blood flow and contractility. Although
marked differences are apparent with respect to these actions, little
consensus regarding mechanism has been reached. The present investigation
is directed toward an analysis of differences between muscarinic effects on
cardiac automaticity and conduction. Recent evidence suggests that
potential inhomogeneities in muscarinic receptor behavior might underlie
some of these differences. Moreover, we have found that cholinergic
efficacy at the sinus node is profoundly modulated by the perfusion
characteristics of acetylcholine delivered through the sinus node artery.
Whether this factor contributes to differences in cholinergic
responsiveness is, however, unknown. Thus, experiments are planned which
will analyze potential interrelationships between pharmacological and
mechanical effects of acetylcholine on the sinus and AV nodes.
Agonist and/or antagonist drugs will be administered via the sinus and AV
node arteries under rigidly controlled perfusion conditions. The
differences between muscarinic responses to vagal stimulation and exogenous
agonist administration will be explored. Additional experiments will
ascertain whether differences in complex autonomic interactions (ie:
accentuated antagonism) are responsible for differences in cholinergic
efficacy at the sinus and AV nodes.
The information derived from these studies will be of importance in
delineating more clearly the complex effects of parasympathetic activation
on the heart. Further understanding of parasympathetic mechanisms involved
in normal cardiac function (automaticity and conduction) is essential for a
complete understanding of the alterations in neural control evident in
pathophysiological states. The possibility for the existence of
inhomogeneities in muscarinic receptor subtypes within the heart may
provide the impetus for the development of new pharmacologic agents which
could selectively influence cholinergic function in the heart.
乙酰胆碱对心血管的影响包括:
自律性、传导、冠状动脉血流量和收缩性。 虽然
这些行动之间存在明显差异,但差异不大
就机制问题达成了共识。 本研究
是针对毒蕈碱作用之间的差异进行分析,
心脏自律性和传导。 最近的证据表明
毒蕈碱受体行为的潜在不均匀性可能是
其中的一些差异。 此外,我们还发现,
窦房结处的功效受到灌注的深刻调节
通过窦房结动脉输送的乙酰胆碱的特征。
这个因素是否会导致胆碱能神经元
然而,反应是未知的。 因此,计划进行的实验
将分析药理学和
乙酰胆碱对窦和房室结的机械作用。
激动剂和/或拮抗剂药物将通过窦和AV给药
在严格控制的灌注条件下的结动脉。 的
迷走神经刺激和外源性刺激的毒蕈碱反应之间的差异
将探索激动剂施用。 其他实验将
确定复杂自主交互的差异(即:
增强的拮抗作用)是导致胆碱能神经递质的差异的原因。
窦和房室结的疗效。
从这些研究中获得的信息将对
更清楚地描绘了副交感神经激活的复杂效应
在心脏上 进一步了解副交感神经机制
在正常心脏功能(自律性和传导)中,
完全理解神经控制的变化,
病理生理状态。 存在的可能性
心脏内毒蕈碱受体亚型的不均一性可能
为开发新的药物制剂提供动力,
可以选择性地影响心脏的胆碱能功能。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Beat-by-beat modulation of AV conduction. II. Autonomic neural mechanisms.
AV 传导的逐节拍调制。
- DOI:10.1152/ajpheart.1986.251.6.h1134
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Warner,MR;deTarnowsky,JM;Whitson,CC;Loeb,JM
- 通讯作者:Loeb,JM
Autoregulation of cardiac cycle length: role of catecholamines.
心动周期长度的自动调节:儿茶酚胺的作用。
- DOI:
- 发表时间:1984
- 期刊:
- 影响因子:0
- 作者:Loeb,JM;deTarnowsky,JM;Doerschuk,SH;Whitson,CC
- 通讯作者:Whitson,CC
Parasympathomimetic effects of fentanyl on the canine sinus node.
芬太尼对犬窦房结的拟副交感神经作用。
- DOI:10.1016/0165-1838(84)90010-9
- 发表时间:1984
- 期刊:
- 影响因子:0
- 作者:Loeb,JM;Lichtenthal,PR;deTarnowsky,JM
- 通讯作者:deTarnowsky,JM
Dynamic interactions between heart rate and atrioventricular conduction.
心率和房室传导之间的动态相互作用。
- DOI:10.1152/ajpheart.1985.249.3.h505
- 发表时间:1985
- 期刊:
- 影响因子:0
- 作者:Loeb,JM;deTarnowsky,JM;Warner,MR;Whitson,CC
- 通讯作者:Whitson,CC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEROD M LOEB其他文献
JEROD M LOEB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEROD M LOEB', 18)}}的其他基金
CHOLINERGIC ACTIVATION: AUTOMATICITY AND CONDUCTION
胆碱能激活:自动性和传导
- 批准号:
3340182 - 财政年份:1982
- 资助金额:
$ 8.82万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 8.82万 - 项目类别: